Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SITAGLIPTIN Cause Diverticulum intestinal? 75 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Diverticulum intestinal have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.4% of all adverse event reports for SITAGLIPTIN.

75
Reports of Diverticulum intestinal with SITAGLIPTIN
0.4%
of all SITAGLIPTIN reports
54
Deaths
70
Hospitalizations

How Dangerous Is Diverticulum intestinal From SITAGLIPTIN?

Of the 75 reports, 54 (72.0%) resulted in death, 70 (93.3%) required hospitalization, and 19 (25.3%) were considered life-threatening.

Is Diverticulum intestinal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922) Diabetes mellitus inadequate control (744) Diarrhoea (712) Hypoglycaemia (674)

What Other Drugs Cause Diverticulum intestinal?

OLMESARTAN MEDOXOMIL (641) HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL (479) ADALIMUMAB (167) ASPIRIN (152) PANTOPRAZOLE (124) VALSARTAN (106) METHOTREXATE (98) TORSEMIDE (95) CLOPIDOGREL BISULFATE (83) APIXABAN (81)

Which SITAGLIPTIN Alternatives Have Lower Diverticulum intestinal Risk?

SITAGLIPTIN vs SOAP SITAGLIPTIN vs SODIUM SITAGLIPTIN vs SODIUM BICARBONATE SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM SITAGLIPTIN vs SODIUM BORATE

Related Pages

SITAGLIPTIN Full Profile All Diverticulum intestinal Reports All Drugs Causing Diverticulum intestinal SITAGLIPTIN Demographics